Sorry, you need to enable JavaScript to visit this website.

News

Ochsner Health announces first enrollment for Phase 2/3 study of vaccine for Covid-19

Ochsner Health announces first enrollment for Phase 2/3 study of vaccine for Covid-19

Ochsner Health announced plans to participate as a study site for the Phase 2/3 global study sponsored by Pfizer Inc. and BioNTech SE of an investigational vaccine, BNT162b2, against SARS-CoV-2 (commonly known as COVID-19). The health system has already had multiple participants enroll.

Pages

The Inquisitor

1915 Citizens Bank Drive
Bossier City, LA. 71111
(318) 929-5152